Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma

Por Su-xia Han, Jun-lan Wang, Xi-jing Guo, Chen-chen He, Xia Ying, Jin-lu Ma, Yuan-yuan Zhang, Qian Zhao, Qing Zhu
Publicado em 2014-01-01